- Zomedica has become a preferred provider of advanced veterinary solutions to the Veterinary Management Groups membership network.
- The agreement is effective Sept. 1, 2026, through Aug. 31, 2028.
- VMG members will receive preferred access to Zomedica technologies including PulseVet, Assisi, VETIGEL, TRUFORMA and VETGuardian PLUS.
- The portfolio includes technologies for shock wave therapy, targeted pulsed electromagnetic field therapy, hemostasis, point-of-care diagnostics and remote patient monitoring.
- VMG is a membership network for independent veterinary practice owners across the United States.
Zomedica Corp. has announced a strategic partnership with Veterinary Management Groups (VMG), establishing the animal health company as a preferred provider of veterinary technologies to the VMG membership network.
The agreement is effective Sept. 1, 2026, through Aug. 31, 2028.
As part of the partnership, VMG members will receive preferred access to several Zomedica technologies. These include the PulseVet shock wave therapy system for companion and equine patients and Assisi targeted pulsed electromagnetic field therapy devices designed to support management of pain, inflammation and anxiety in companion animals.
The agreement also covers VETIGEL hemostatic gel; the TRUFORMA point-of-care diagnostic platform, which offers in-clinic endocrine testing including ACTH, cortisol and progesterone; and the VETGuardian PLUS remote monitoring platform for real-time, contactless patient oversight.
Supporting independent practices
“Zomedica is proud to partner with an organization like VMG, which is deeply committed to empowering independent practices,” said Larry Heaton, chief executive officer at Zomedica. “We’re excited to offer our portfolio of innovative solutions to a community that values clinical excellence, practice growth, and patient-centered care.”
Matt Salois, president of Veterinary Study Groups (VMG), said the partnership will bring Zomedica technologies to VMG members while supporting the organization’s focus on clinical outcomes and operational efficiency.
“At VMG, our mission is to empower independent practices to deliver the highest standard of care possible,” Salois said. “Partnering with Zomedica allows us to bring cutting-edge technologies to our members – solutions that truly elevate clinical outcomes and operational efficiency.”
Kevin Klass, senior vice president of sales at Zomedica, said the agreement creates an opportunity to expand access to the company’s solutions across VMG’s network of veterinary clinics.
Veterinary Management Groups
Founded in 1984 by veterinarians, VMG is a membership network for independent veterinary practice owners across the United States. It brings clinic owners together in peer-to-peer study groups focused on business growth, reducing professional isolation and increasing hospital profitability.
VMG serves more than 2,400 member practices and provides financial benchmarking and data-tracking platforms, group purchasing opportunities with preferred industry partners, and leadership and development programs.
Zomedica
Zomedica is an equine and companion animal healthcare company providing therapeutic and diagnostic products. Its portfolio includes PulseVet, the Assisi Loop line, TRUFORMA, TRUVIEW, VetGuardian PLUS and VETIGEL.
Headquartered in Michigan, Zomedica employs approximately 150 people and manufactures and distributes products from facilities in Georgia and Minnesota. The company reported revenue growth of 17% in 2025 to $32 million and approximately $44 million in liquidity as of June 30, 2026.
Information sourced from the company’s press release.
